The problem with A to Z and bestseller lists

An alphabetical list treats every compound as an island. BPC-157 sits nowhere near TB-500, though they appear together constantly in the tissue-repair literature, and a researcher browsing the letter B learns nothing about what belongs alongside it. Sorting by popularity is worse, because it organises the catalogue around commercial metrics rather than scientific ones; the compound most bought is not necessarily the compound most relevant to your work. Both arrangements force researchers to arrive already knowing exactly what they want, and give them nothing when they do.

Organising by mechanism instead

Mechanism-based organisation groups compounds by the biological system in which they are studied. That mirrors how research actually proceeds: nobody studies the alphabet, people study tissue repair, energy metabolism or hormonal signalling. Group the catalogue the way researchers think, and the catalogue starts doing useful work, because the compounds adjacent to the one you came for are the ones most likely to matter to your question.

The five categories, with what lives in each

Tissue research. Compounds examined in preclinical models of repair, remodelling and inflammation, including BPC-157, TB-500, GHK-Cu, KPV and their combined preparations.

Cellular research. Compounds used in the study of cellular metabolism, mitochondrial signalling and oxidative stress, including MOTS-c, NAD+ and glutathione.

Neural research. Peptides investigated in neurological and behavioural research, including the Russian-developed heptapeptides Semax and Selank.

Metabolic research. Compounds studied in energy metabolism and receptor pharmacology, including the triple receptor agonist Retatrutide, the growth hormone fragment AOD-9604, and the NNMT inhibitor 5-Amino-1MQ.

Endocrine research. Peptides used in hormone-signalling research, including CJC-1295 (No-DAC), its combination with Ipamorelin, and Kisspeptin-10.

What adjacency does for a researcher

The quiet benefit of this structure is discovery. A researcher who arrives for CJC-1295 sees Kisspeptin-10 in the same section and learns the catalogue covers reproductive-axis signalling too. Someone comparing single compounds against combinations finds the blends listed beside their components, with the honest caveat that evidence for components is not evidence for a combination. Each product page reinforces the structure with a studied-alongside module linking to mechanistically related compounds, so the catalogue behaves less like a shop shelf and more like a map of the research landscape.